STAT+: U.K. agency declines to recommend Eli Lilly’s Mounjaro for type 2 diabetes
STAT
JUNE 26, 2023
government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence. LONDON — A U.K. Mounjaro, also known as tirzepatide, has U.S.
Let's personalize your content